This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Turning Point Brands (TPB) Catches Eye: Stock Jumps 7.6%
by Zacks Equity Research
Turning Point Brands (TPB) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
3 Reasons Why Growth Investors Shouldn't Overlook Turning Point Brands, Inc. (TPB)
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Turning Point Brands, Inc. (TPB) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) delivered earnings and revenue surprises of 34.21% and 7.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Chesapeake Utilities, Conagra Brands, Innovative Industrial Properties, Turning Point Brands and Super League Gaming
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chesapeake Utilities, Conagra Brands, Innovative Industrial Properties, Turning Point Brands and Super League Gaming
5 Recession-Proof Stocks for Coronavirus-Led Mass Layoffs
by Tirthankar Chakraborty
The coronavirus pandemic wiped out job gains and slammed the U.S. economy. But contrary to popular belief, there are stocks that do well during economic downturns, like defensive and vice stocks.
The Zacks Analyst Blog Highlights: Ensign, Gaia, MEI Pharma, Turning Point Brands and A10 Networks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ensign, Gaia, MEI Pharma, Turning Point Brands and A10 Networks
5 Top Stocks That Have Skyrocketed in the Past 7 Days
by Nalak Das
Despite the coronavirus-induced market downturn, a handful of stocks have soared in the last seven trading days defying the overall market trend.
Is Turning Point Brands, Inc. (TPB) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Turning Point Brands, Inc. (TPB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The Zacks Analyst Blog Highlights: Calix, CBIZ, The Ensign Group, Regeneron Pharmaceuticals and Turning Point Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Calix, CBIZ, The Ensign Group, Regeneron Pharmaceuticals and Turning Point Brands
Market is Wavering! Buy 5 Best Low-Volatility Stocks Now
by Tirthankar Chakraborty
Low-volatility stocks tend to hold up better in tough times. More interestingly, these stocks have done better over longer periods of time, even before the coronavirus-induced market crash.